The firm, founded in 2012, has over $2 billion in capital under management and offices in Menlo Park, Shanghai, and New York. Decheng Capital provides capital and strategic support to early stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence. The firm's team of dedicated professionals has a track record of building highly successful companies globally and is poised to deliver superior returns for investors and create value for entrepreneur partners.